跳至主要内容
临床试验/CTRI/2012/07/002827
CTRI/2012/07/002827招募中3 期

Indian Trial of Endocardial Ventricular Substrate Ablation to Prevent Recurrent VT Events (INTERVENE) - INTERVENE

CARE Hospital0 个研究点目标入组 132 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
132

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • more than 18 and less than 85 years of age
  • History of a remote MI of more than 1 month
  • Survival of a ventricular arrhythmic event VT or VF that would mandate placement of an implantable cardioverter-defibrillator
  • Patient cannot afford an ICD and thus has been planned for treatment with Amiodarone
  • Ability to understand the requirements of the study
  • Willingness to adhere to study restrictions and comply with all postprocedural follow-up requirements

排除标准

  • Patients with NYHA class IV congestive heart failure
  • Prior ablation for a ventricular arrhythmia
  • Presence of an LV thrombus
  • Contraindication to anticoagulation
  • Inability to access the endocardium because of mechanical mitral and aortic valve
  • Life expectancy of less than 1 year for any medical condition

研究者

发起方
CARE Hospital

相似试验